(Q41519678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Autoimmune disease in pregnancy. Systemic lupus erythematosus and antiphospholipid syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

R M Silver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D W Branch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

published in

Clinics in Perinatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

291-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

Sixty-six cases of intrauterine fetal death. A prospective study with an extensive test protocol

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Sex hormonal effects on the severity of streptococcal cell wall-induced polyarthritis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Systemic lupus erythematosus: current state of the genetic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy: Antiphospholipid antibodies and human reproductive failure

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies in early repeated abortions: a case-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Age and sex associations of 40 autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Fetal hydrops and congenital complete heart block: response to maternal steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy in lupus nephritis and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies and risk of intrauterine late fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Steroids during pregnancy and possible fetal consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Obstetric complications associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies and cerebral ischemia in young people

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus nephropathy and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The effects of pregnancy on autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Ocular toxicity of antimalarial drugs. Long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Association of maternal systemic lupus erythematosus with congenital complete heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Successful in utero therapy of fetal heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Localization of Ro (SS-A) antigen in the cardiac conduction system

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy in systemic lupus erythematosus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Systemic lupus erythematosus in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pathophysiology of antiphospholipid antibodies: absence of prostaglandin-mediated effects on cultured endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Congenital heart block and maternal systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus anticoagulant and the fibrinolytic system in young patients with stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Systemic Lupus Erythematosus in Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Systemic lupus erythematosus and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Outcome of isolated congenital complete heart block diagnosed in utero

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Syndrome of the black swan

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effect of pregnancy in patients with lupus nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

C4 and plasma protein in hypertension during pregnancy with and without proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy in women with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus anticoagulant in women with multiple spontaneous miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Congenital heart block and widespread fibrosis due to maternal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy and its outcome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy in lupus nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

What is the "true" antigen for anticardiolipin antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Evaluation of lupus nephritis during pregnancy by renal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The transfer and metabolism of corticosteroids in the perfused human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Obstetric outcome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy does not cause systemic lupus erythematosus to worsen

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Does lupus flare during pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Answers to the antiphospholipid-antibody syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pathogenesis of the antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Fetal survival after prednisone suppression of maternal lupus-anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus anticoagulant in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Ototoxicity of Chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Maternal and fetal outcome in neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effect of pregnancy on course of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Intrauterine death and circulating anticoagulant ("antithromboplastin")

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Neonatal complications after the administration of indomethacin for preterm labor

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Fetal loss treatment in patients with antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies and fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anti-phospholipid antibodies and pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Interlaboratory variation in antiphospholipid antibody testing

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The immunoglobulin G fraction from plasma containing antiphospholipid antibodies causes increased placental thromboxane production

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The Hopkins Lupus Pregnancy Center: 1987–1991 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

CLEFT PALATE IN THE MOUSE: A TERATOGENIC INDEX OF GLUCOCORTICOID POTENCY

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Long-term outcome of mothers of children with complete congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Previous Pregnancy Outcome Is an Important Determinant of Subsequent Pregnancy Outcome in Women With Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

LUPUS-LIKE ANTICOAGULANT IN PREGNANCY

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Recurrent adverse pregnancy outcome and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Androgenic hormones modulate autoantibody responses and improve survival in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anti-cardiolipin antibodies and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effect of long-acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Anticardiolipin antibodies: clinical consequences of "low titers"

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibodies in pre‐eclamptic women: Relation to growth retardation and neonatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Aspirin and congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Systemic lupus erythematosus associated with klinefelter's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Hypocalciuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Maternal antibodies against fetal cardiac antigens in congenital complete heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Neonatal lupus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Lupus and pregnancy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Pregnancy in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Autoantibody-associated congenital heart block: outcome in mothers and children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930168-4

7 January 2021

10.1016/S0095-5108(18)30168-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209805%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference